Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase (Q37337988)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1991

edit

Language	Label	Description	Also known as
English	Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase	scientific article published on January 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

main subject

pharmacology

1 reference

based on heuristic

inferred from title

author name string

H Y Pan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

publication date

1 January 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

published in

European Journal of Clinical Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

volume

40 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

page(s)

S15-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

cites work

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF03216282

retrieved

21 January 2018

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF03216282

retrieved

21 January 2018

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF03216282

retrieved

21 January 2018

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1904355

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1904355

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF03216282

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

PubMed publication ID

1904355

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1904355

retrieved

19 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37337988&oldid=2200192907"